Application no. and date | 09779096.8 (espacenet) (Federated) (European Patent Register), 20090226 | Patent/reg. no. and date | DK/EP 2400950, 20190522 | Publication date | 20120104 | Priority no. and date | | EP pub. no. and date |
EP 2400950 20120104 | Effective date | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | P81903115DK00E | Inventor | THOMAS, Marian, GlaxoSmithKline
Park Road
Ware
Hertfordshire SG12 0DP, GB, BAKER, Darrell, GlaxoSmithKline Stockley Park West
Uxbridge Middlesex UB11 1BT, GB, BRUCE, Mark, GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/138 (2006.01) , A61K 31/58 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 11/08 (2006.01) | Title | FARMACEUTISKE FORMULERINGER OMFATTENDE 4-{(1 R)-2-[(6-{2-[(2,6-DICHLORBENZYL)OXY]ETHOXY}HEXYL)AMINO]-1-HYDROXYETHYL}-2-(HYDROXYMETHYL)PHENOL | Int. application no. | EP2009052306 | Int. publication no. | WO2010097115 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|